Natesto
Product Images NDC 69654-239

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Natesto (NDC 69654-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aytu Bioscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Nat07 0000 01)

An instructional line drawing showing a person administering Natesto nasal gel. The person is depicted applying the nasal gel by inserting the applicator tip into one nostril with their finger on the device, illustrating the correct way to use the nasal spray dosage form.*

FDA Label Image

Figure (Nat07 0000 02)

An instructional line drawing depicting a person properly administering Natesto nasal spray by placing the spray nozzle into one nostril while holding the bottle with the thumb underneath and fingers on top. The illustration demonstrates correct positioning for nasal delivery.*

FDA Label Image

Figure (Nat07 0000 03)

An instructional diagram showing the internal parts of a Natesto nasal gel delivery system. The image labels the piston and the gel level indicator inside the clear cylindrical container, illustrating how the gel level changes as the product is used.*

FDA Label Image

Figure (Nat07 0000 04)

Chemical structure of the active ingredient in Natesto, showing a steroidal molecular framework with labeled functional groups including hydroxyl and ketone groups, along with molecular weight 288.4 and molecular formula C19H28O2.*

FDA Label Image

Figure 1 (Nat07 0000 05)

A line chart showing mean total serum testosterone concentration (ng/dL) with standard deviation error bars plotted against time (hours) over a 24-hour period. The graph depicts fluctuating testosterone levels with three distinct peaks occurring approximately around 0, 10, and 16 to 18 hours.*

FDA Label Image

Figure A (Nat07 0000 06)

A black and white instructional illustration of the Natesto nasal gel dispenser parts, including labeled components such as Actuator, Pump, Tip, Hole, Gel Level Indicator, Piston, Indicator Window, Dispenser, and Cap. The diagram details the dispenser's structure and how it functions.*

FDA Label Image

Figure B (Nat07 0000 07)

An instructional line drawing showing a side view of a hand holding a nasal spray device aimed for administration into a nostril. This diagram likely illustrates how to use the Natesto nasal spray product.*

FDA Label Image

Figure C (Nat07 0000 08)

An instructional line drawing illustrating a person applying a nasal spray, designed to show the correct method of administration for Natesto nasal testosterone gel.*

FDA Label Image

Figure D (Nat07 0000 09)

An instructional illustration showing a person using Natesto by applying the nasal spray. The image depicts the correct hand positioning and nose insertion for administering the nasal spray dose, emphasizing proper usage technique.*

FDA Label Image

Figure E (Nat07 0000 10)

An instructional line drawing depicting a person administering intranasal medication by inserting the applicator into one nostril with the head slightly tilted back. The image illustrates the proper technique for nasal spray medication use.*

FDA Label Image

Figure F (Nat07 0000 11)

Instructional illustration showing a person administering Natesto nasal spray by placing the device in the nostril and pressing the pump downward to deliver the spray. The figure demonstrates the proper hand position and spray direction for nasal administration.*

FDA Label Image

Figure G (Nat07 0000 12)

An instructional illustration showing a person inserting their thumb and fingers into their nostrils, demonstrating how to administer a nasal spray. The image is simple and black-and-white, focusing on the proper hand placement on the nose.*

FDA Label Image

Figure H (Nat07 0000 13)

An instructional illustration showing a portion of the Natesto nasal gel delivery device. The image highlights the gel level indicator and piston, identifying key components for use or inspection.*

FDA Label Image

Principal Display Panel (Natesto Nasal Gel Carton)

Packaging label for Natesto (testosterone) nasal gel, 5.5 mg per actuation, marketed by Aytu BioScience, Inc. The label states each actuation delivers 0.122 g of gel and indicates it is for intranasal use only. The package includes warnings that it is not child resistant and should be kept out of reach of children. Manufactured by Haupt Pharma Amareg GmbH in Germany. Total contents listed as 11 g per dispenser.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.